• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在美国健康与退休研究中,16岁之前的暴露情况和条件与成年人患痴呆症的发病率相关。

Exposures and conditions prior to age 16 are associated with incidence of dementia status among adults in the United States Health and Retirement Study.

作者信息

Cockell Scarlet, Wang Herong, Benke Kelly S, Ware Erin B, Bakulski Kelly M

机构信息

Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.

Department of Mental Health, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.

出版信息

J Alzheimers Dis. 2025 Aug 14:13872877251365283. doi: 10.1177/13872877251365283.

DOI:10.1177/13872877251365283
PMID:40808583
Abstract

BackgroundDementia and cognitive impairment are prevalent conditions, and susceptibility likely begins years before symptoms. Early life has not been comprehensively tested for potential risk factors for dementia.ObjectiveTo explore the associations between childhood conditions and exposures and cognitive impairment in adulthood.MethodsIn the US Health and Retirement Study (normal baseline cognition; n = 16,509; 2008-2018 waves), 31 exposures before age 16 were retrospectively assessed with ten-year incident cognitive status (dementia, impaired, normal). Using parallel modified Poisson models, each exposure was tested with incident cognition, adjusting for sex, baseline age, follow-up, race/ethnicity, personal/parental education.ResultsAmong the analytic sample, participants were mean 61 years of age at baseline and all had normal cognition. During up to 10 years of follow-up, 14.5% developed cognitive impairment and 5.3% developed dementia. Participants with depression during childhood had 1.49 (95%CI:1.2,1.84) times higher risk of incident impairment, relative to normal cognition. Participants with headaches/migraines during childhood had 1.43 (95%CI:1.14,1.79) times higher risk of incidence of dementia. Participants with learning problems during childhood had 1.71 (95%CI:1.44,2.03) times higher risk of incident impairment. Childhood self-rated health of fair (1.59, 95%CI:1.2,2.1) and poor (2.42, 95%CI:1.62,3.61) had higher risk of incidence of dementia, relative to excellent self-rated health. Associations between additional exposures and either incident impairment or dementia did not reach the multiple testing threshold (false discovery rate < 0.01).ConclusionsConditions and exposures during the early life period may be important for later life cognitive impairment or dementia. These findings support extending the relevant dementia risk window to evaluate childhood.

摘要

背景

痴呆和认知障碍是常见病症,易感性可能在症状出现前数年就已开始。早年生活中的潜在痴呆风险因素尚未得到全面检验。

目的

探讨儿童时期的状况和暴露因素与成年后认知障碍之间的关联。

方法

在美国健康与退休研究中(基线认知正常;n = 16509;2008 - 2018年各波次),回顾性评估了16岁之前的31种暴露因素与十年期的认知状态(痴呆、受损、正常)。使用平行修正泊松模型,对每种暴露因素与新发认知情况进行检验,并对性别、基线年龄、随访情况、种族/族裔、个人/父母教育程度进行校正。

结果

在分析样本中,参与者基线时的平均年龄为61岁,且认知均正常。在长达10年的随访期间,14.5%的人出现了认知障碍,5.3%的人患上了痴呆。童年时期患抑郁症的参与者出现新发认知障碍的风险比认知正常者高1.49倍(95%置信区间:1.2,1.84)。童年时期患头痛/偏头痛的参与者患痴呆症的风险比正常情况高1.43倍(95%置信区间:1.14,1.79)。童年时期有学习问题的参与者出现新发认知障碍的风险高1.71倍(95%置信区间:1.44,2.03)。童年时期自我评定健康状况为中等(1.59,95%置信区间:1.2,2.1)和较差(2.42,95%置信区间:1.62,3.61)的参与者患痴呆症的风险相对于自我评定健康状况极佳者更高。其他暴露因素与新发认知障碍或痴呆之间的关联未达到多重检验阈值(错误发现率<0.01)。

结论

早年时期的状况和暴露因素可能对晚年的认知障碍或痴呆很重要。这些发现支持将相关痴呆风险窗口扩展至童年时期进行评估。

相似文献

1
Exposures and conditions prior to age 16 are associated with incidence of dementia status among adults in the United States Health and Retirement Study.在美国健康与退休研究中,16岁之前的暴露情况和条件与成年人患痴呆症的发病率相关。
J Alzheimers Dis. 2025 Aug 14:13872877251365283. doi: 10.1177/13872877251365283.
2
Exposures and conditions prior to age 16 are associated with dementia status among adults in the United States Health and Retirement Study.在美国健康与退休研究中,16岁之前的暴露情况和条件与成年人的痴呆症状态相关。
medRxiv. 2024 Aug 19:2024.08.15.24312018. doi: 10.1101/2024.08.15.24312018.
3
CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).脑脊液tau蛋白及脑脊液tau蛋白与β淀粉样蛋白比值在轻度认知障碍(MCI)患者中用于诊断阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2017 Mar 22;3(3):CD010803. doi: 10.1002/14651858.CD010803.pub2.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Clinical judgement by primary care physicians for the diagnosis of all-cause dementia or cognitive impairment in symptomatic people.初级保健医生对有症状人群进行全因痴呆或认知障碍诊断的临床判断。
Cochrane Database Syst Rev. 2022 Jun 16;6(6):CD012558. doi: 10.1002/14651858.CD012558.pub2.
6
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.加兰他敏治疗阿尔茨海默病所致痴呆和轻度认知障碍。
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
7
Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).血浆和脑脊液β淀粉样蛋白用于诊断轻度认知障碍(MCI)患者的阿尔茨海默病性痴呆及其他痴呆。
Cochrane Database Syst Rev. 2014 Jun 10;2014(6):CD008782. doi: 10.1002/14651858.CD008782.pub4.
8
Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis.胆碱酯酶抑制剂治疗血管性痴呆和其他血管性认知障碍:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.
9
Algorithm-based pain management for people with dementia in nursing homes.基于算法的养老院痴呆患者疼痛管理。
Cochrane Database Syst Rev. 2022 Apr 1;4(4):CD013339. doi: 10.1002/14651858.CD013339.pub2.
10
Donepezil for dementia due to Alzheimer's disease.多奈哌齐用于治疗阿尔茨海默病所致的痴呆。
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.

引用本文的文献

1
The Cerebral Lymphatic System: Function, Controversies, and Therapeutic Approaches for Central Nervous System Diseases.脑淋巴系统:中枢神经系统疾病的功能、争议及治疗方法
Cell Mol Neurobiol. 2025 Aug 19;45(1):80. doi: 10.1007/s10571-025-01598-2.